Faculty

Silvia de Sanjose Llongueras

Affiliate Professor, Epidemiology


Education

MD Medicine & Surgery, University of Barcelona, 1980
MSc Epidemiology, London School of Hygiene & Tropical Medicine (UK), 1986
PhD Epidemiology, London School of Hygiene & Tropical Medicine (UK), 1989

Contact


ISGlobal
Barcelona,

Bio

Dr. de Sanjose is a Medical Doctor from the University of Barcelona, Spain and PhD from the London University, UK. She is an epidemiologist working on HPV-related diseases for over 35 years. She has been employed at WHO- IARC, at the Catalan Institute of Oncology in Barcelona, Spain, at PATH in Seattle, and at the USA National Cancer Institute. She is the Past President of the International PapillomaVirus Society (2015-18). She is an associated researcher at ISGlobal in Barcelona, Spain and has a grant with Dr Margaret Madeline and Ann Durr from the Fred Hutch.

She is interested in the pathways of cervical cancer prevention and all HPV-related cancers through vaccination and secondary prevention and adequate management. She co-leads a Moonshoot-related project, the PAVE project, which primarily emphasizes the utilization of HPV detection through self-sampling, extended genotype information, and, for women who test positive for HPV, the automated evaluation of cervical images using AI-based solutions to enhance visual assessment with acetic acid. She is involved in shaping the World Health Organization's living guidelines for cervical cancer screening and the Code of Cancer Prevention for Europe.

Research Areas

Research Interests

I am interested in the pathways of cervical cancer prevention and all HPV-related cancers through vaccination and secondary prevention and adequate management. In particular I am involved in improving cervical cancer screening in poor resource settings.

Recent Publications (PubMed)

Comparative distribution of HPV genotypes in penile and vulvar squamous cell carcinomas with basaloid or warty (condylomatous) features.
(2026 Sep 12)
Hum Pathol
Sánchez DF, Fernández-Nestosa MJ, Cañete-Portillo S, Lobatti A, Santacruz L, Lloveras B, Ordi J, Allemany L, Muñoz N, de Sanjosé S, Bosch X, Cubilla AL, HPV VVAP Study Group
FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.
(2026 Sep)
Int J Gynecol Cancer 36(9): 104946
Pareja R, Heredia F, Sánchez-Díaz E, Cuello MA, de Sanjosé S, Jerónimo J, Garland SM, Pino MD, Fletcher A, Torné A, Levin G, Flowers L, Ndukwe MI, Trujillo LM, Wilailak S, Bhatla N, Fotopoulou C, Schmalfeldt B, Sánchez GI, Kyrgiou M, Petignat P, Abu-Rustum N
FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.
(2026 Sep 1)
Int J Gynaecol Obstet
Pareja R, Heredia F, Sánchez-Díaz E, Cuello MA, de Sanjosé S, Jerónimo J, Garland SM, Del Pino M, Fletcher A, Torné A, Levin G, Flowers L, Ndukwe MI, Trujillo LM, Wilailak S, Bhatla N, Fotopoulou C, Schmalfeldt B, Sánchez GI, Kyrgiou M, Petignat P, Abu-Rustum N
Challenging the assumption that experience- and training-related factors improve accuracy of cervical cancer screening image interpretation: Evidence from Tanzania.
(2026)
PLOS Glob Public Health 6(8): e0007074
Inturrisi F, Yuma S, Mchome B, Mremi A, Marandu PD, West N, Chelva M, Datta RR, Simpson A, Ajenifuja KO, Adepiti CA, Desai KT, Wentzensen N, Boyd-Morin J, Egemen D, Jeronimo JA, de Sanjosé S, Schiffman M, Yeates K
SPEACx: a screening pathway-based evaluation and audit framework of cervical cancer diagnostic routes in a population-based programme.
(2026 Jul 21)
Arch Public Health 84(1):
Del Valle D, Lamo EA, Expósito AD, Amorín ÁG, Camacho ER, Menéndez AR, Conde JCQ, Coccoz LB, Miranda JWC, de Sanjosé S
Show complete publication list

In the News

No news articles at this time.